Dr. Ing. h.c. F. Porsche AG (ETR:P911)

Market Cap	56.14B
Revenue (ttm)	38.96B
Net Income (ttm)	3.98B
Shares Out	911.00M
EPS (ttm)	n/a
PE Ratio	14.10
Forward PE	13.31
Dividend	2.31 (5.41%)
Ex-Dividend Date	Invalid Date

Volume	683,715
Average Volume	944,343
Open	44.06
Previous Close	43.79
Day's Range	43.91 - 45.46
52-Week Range	39.58 - 75.00
Beta	1.07
RSI	56.05
Earnings Date	Mar 12, 2025

About Achilles Therapeutics

Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services business in Germany, Europe, North America, China, and internationally. The company develops, manufactures, and sells vehicles. It also offers customer and dealer financing, leasing, and mobility and other finance-related services. The company was formerly known as Porsche Fünfte Vermögensverwaltung AG and changed its name to Dr. Ing. h.c. F. Porsche AG in November 2009. The company was incorporated in 2009 and is headquartered in Stuttgart, Germany. Dr. Ing. h.c. F. Porsc...

• Industry: Motor Vehicles and Passenger Car Bodies
• Sector: Consumer Discretionary
• Founded: 2009
• Employees: 41,039
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: P911